Ionis Pharmaceuticals Is Maintained at Neutral by JP Morgan

Dow JonesMar 24 20:57 · Ratings

Praxis Precision Medicines to Present on Late-Stage Programs Across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswireMar 24 20:00

J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $45

Futu NewsMar 24 18:31 · Ratings

Another "big pharma" market is rising.

Which pharmaceutical companies are likely to break through?

Zhitong FinanceMar 23 07:09

Why Is Ionis Pharmaceuticals (IONS) Up 0.1% Since Last Earnings Report?

Yahoo FinanceMar 21 23:30

Is Ionis Pharmaceuticals (NASDAQ:IONS) Weighed On By Its Debt Load?

Simply Wall StMar 17 18:03